Clinical Trial Update: Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating pyrotinib in combination with vinorelbine for HER2-positive locally advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer, Pyrotinib | Phase 2 | Status: UNKNOWN